Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan

Affiliations

• ¹ Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
• ² Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku, Tokyo, Japan.
• ³ Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁴ Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku, Tokyo, Japan. Electronic address: mizoue@hosp.ncgm.go.jp.
• ⁵ Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁶ Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁷ Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁸ Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
• ⁹ Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.